Form 4: Hims & Hers Health, Inc. Executive Nader Kabbani Reports Acquisition of Restricted Stock Units
SEC Filing Form 4
Chief Operating Officer of Hims & Hers Health, Inc., Nader Kabbani, reports the acquisition of 216,333 Restricted Stock Units (RSUs) tied to Class A Common Stock.
Summary
- Nader Kabbani, the Chief Operating Officer of Hims & Hers Health, Inc., filed a Form 4 on May 20, 2025, reporting a transaction.
- On May 19, 2025, Kabbani acquired 216,333 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Class A Common Stock.
- The RSUs vest over a 4-year period, with 25% vesting on June 15, 2026, and the remaining 75% vesting in equal quarterly installments thereafter.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and aligns the executive's interests with the company's long-term performance. There are no immediate negative implications.
Positives
- The acquisition of RSUs by a key executive like the COO can be seen as a positive sign, indicating confidence in the company's future performance.
Risks
- The value of the RSUs is tied to the performance of Hims & Hers Health, Inc.'s Class A Common Stock, which is subject to market fluctuations.
Future Outlook
The vesting schedule suggests a long-term commitment from the executive to the company's success.
Industry Context
Executive compensation in the form of stock options and RSUs is a common practice in the tech and healthcare industries to align management's interests with those of shareholders.
Comparison to Industry Standards
- Companies like Teladoc Health and GoodRx also utilize RSU grants as part of their executive compensation packages.
- The vesting schedules are generally similar, ranging from 3 to 5 years with quarterly or annual vesting increments.
Stakeholder Impact
- Shareholders may view this as a positive sign of executive commitment.
- Employees may see this as a sign of stability and confidence in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of RSU acquisition |
| 05/20/2025 | Date of Form 4 filing |
| 06/15/2026 | First vesting date for 25% of the RSUs |
Keywords
Form 4, Restricted Stock Units, RSUs, Nader Kabbani, Hims & Hers Health, Inc., Executive Compensation, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.